Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 305 | 310 | 305 | 17 | 0 |
| Gross Profit | 305 | 310 | 305 | 17 | N/A |
| Operating Expenses | 9,058 | 5,000 | 6,163 | 5,559 | 4,434 |
| Operating Income | -8,753 | -4,690 | -5,858 | -5,542 | -4,434 |
| Other Income | -1,577 | -570 | -1,873 | -672 | -477 |
| Pre-tax Income | -10,330 | -5,260 | -7,731 | -6,214 | -4,911 |
| Net Income Continuous | -10,330 | -5,260 | -7,731 | -6,214 | -4,911 |
| Net Income | $-10,330 | $-5,260 | $-7,731 | $-6,214 | $-4,911 |
| EPS Basic Total Ops | -2.85 | -81.60 | -790.85 | -440.52 | -206.30 |
| EPS Basic Continuous Ops | -2.27 | -59.91 | -107.97 | -103.57 | -83.24 |
| EPS Diluted Total Ops | -2.85 | -81.60 | -790.85 | -440.52 | -206.30 |
| EPS Diluted Continuous Ops | -2.27 | -59.91 | -107.97 | -103.57 | -83.24 |
| EBITDA(a) | $-8,700 | $-4,067 | $-5,668 | $-5,371 | $-4,338 |